Participant Disposition
SECONDARY
All 40 randomized participants completed the study and were included in the safety analysis set. The first 10 randomized participants were excluded from the primary endpoint analysis (5 participants each from both treatment sequences) due to an ePRO device failure; the primary and secondary endpoints were successfully collected in the next 30 participants using a completely different ePRO device. All 40 randomized participants were included in the secondary endpoint and safety analysis sets (